Anne Sophie Bajeot
Papers
5
Total Citations
37
H-Index
4
About
Anne Sophie Bajeot is a leading urologic surgeon and researcher whose work centers on advancing the surgical management of bladder cancer, particularly through the refinement and evaluation of robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD). Her major contributions include pioneering cost-effectiveness analyses across European healthcare systems, demonstrating that RARC can be economically viable while maintaining high-quality outcomes. She has also been instrumental in redefining how postoperative morbidity is measured, advocating for the Comprehensive Complication Index over traditional grading systems to capture the true burden of multiple complications after cystectomy. Her research further explores critical perioperative factors, such as the impact of blood transfusions on oncological outcomes and the safety of continuing acetylsalicylic acid during surgery, providing evidence-based guidance for clinical practice. With over 37 citations across her most-cited works, Bajeot’s studies—published in high-impact journals—have shaped international guidelines and surgical protocols. Her multi-institutional registry analyses offer robust, real-world data that directly influence patient care and surgical decision-making, establishing her as a key voice in the evolution of minimally invasive bladder cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5